Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)
Tizanidine Tablet
Product Images NDC 50090-5767
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-5767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)
Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)
Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)
The text describes an improvement in Ashworth Score, although it's not clear what the score refers to. There is mention of a dose of 26.8 mg and three study weeks, with the endpoint being the last observation carried forward.*
Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)
This is a pharmaceutical company named UNICHEM PHARMACEUTICALS (USA), INC.*
Label Image (Lbl500905767)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
